Presentation: Glirid 1: Each tablet contains Glimepiride USP 1 mg. Glirid 2: Each tablet contains Glimepiride USP 2 mg. Glirid 3: Each tablet contains Glimepiride USP 3 mg. Glirid 4: Each tablet contains Glimepiride USP 4 mg. Indications:Non-insulin-dependent (Type 2) diabetes mellitus (NIDDM), whenever hyperglycemia cannot be controlled adequately by diet, physical exercise and weight reduction. Glirid is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycemia cannot be controlled by diet and exercise or in conjunction with an oral hypoglycemic agent.